In summary, we found that HIF-2α enhances glutamine catabolism in myofibroblasts derived from HSCs and inhibits YAP phosphorylation, promoting fibrosis in NAFLD. The gene discussed is YAP1; the disease is metabolic dysfunction-associated steatotic liver disease.